Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05357885 · ClinicalTrials.gov registry record
Quantitative COVID-19 SARS-CoV-2 Antibody Pre and Post Cardiopulmonary Bypass
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 60
- Enrollment target
NCT05357885 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 60 participants.
The verdict
NCT05357885 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study is designed to compare the levels of SARS-CoV-2 antibody prior to cardiopulmonary bypass and after cardiopulmonary bypass (CPB).
Interventions
- DIAGNOSTIC_TEST SARS-CoV-2 Antibody test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-11-17 |
| Est. Completion | 2022-03-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05357885
The ClinicalTrials.gov registry entry for NCT05357885 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SARS-CoV-2 Antibody test is the first listed.
NCT05357885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05357885 about?
NCT05357885 is a clinical study titled "Quantitative COVID-19 SARS-CoV-2 Antibody Pre and Post Cardiopulmonary Bypass". This study is designed to compare the levels of SARS-CoV-2 antibody prior to cardiopulmonary bypass and after cardiopulmonary bypass (CPB).
What is the current status of trial NCT05357885?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2021-11-17. Estimated completion is 2022-03-17.
What interventions are being tested in trial NCT05357885?
The interventions under investigation include: SARS-CoV-2 Antibody test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05357885?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.